##analysisDate=2017-05-29-17-30-09000																																															
##analyzedBy=RingStudy Site C																																															
##exportDate=2017-11-08-10-13-04000																																															
##analysisName=Site C-R2-FFPE_Ref_Std-C-D																																															
##workflowName=Oncomine Focus w2.1 - DNA - Single Sample																																															
##sampleNames=Site C-R2-FFPE Ref Std-C-D																																															
##reference=hg19																																															
##variantGroup=DEFAULT																																															
##filterChain=Site D_NoRef																																															
##searchText=																																															
##chromosome=All																																															
##totalVariantCount=583																																															
##filterInCount=38																																															
##filteredOutCount=545																																															
##hiddenVariantCount=0																																															
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	Allele Coverage	p-value	Phred QUAL Score	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:65310489	T/C	T	SNV		JAK1	exonic	1								38.81	p.(=)		1796	"T=0.6119, C=0.3881"		-	16	NM_002227.2	c.2199A>G	synonymous	-4.13				"Protein kinase domain,Protein tyrosine kinase"	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	"ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway"	"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile"		"T=1099, C=697"	0.00001	4439.04		"T=594/505, C=381/316"	1	
chr1:65312342	G/A	G	SNV		JAK1	exonic	1								31.05	p.(=)		2000	"G=0.6895, A=0.3105"		-	14	NM_002227.2	c.1977C>T	synonymous	-2				"Protein kinase domain,Protein tyrosine kinase"	rs17127063		0.053 (ref)	0.027	0.1076	0.054	YES	"ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway"	"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile"		"G=1379, A=621"	0.00001	3301.34		"G=760/619, A=345/276"	1	
chr1:115256530	GT/TT	GT	SNV		NRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM581;COSM580;COSM12730		"CT=0.00, TT=11.85, TA=0.00"	p.Gln61Lys		1814	"GT=0.8815, CT=0.0, TT=0.1185, TA=0.0"		-	3	NM_002524.4	c.181C>A	missense	"2.62,0.35"	0.01	53	0.948	"Miro-like protein,Ras family"	rs121913254							"GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,axon guidance,blood coagulation,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane fraction,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,striated muscle cell differentiation,visual learning"		untested	"GT=1599, CT=0, TT=215, TA=0"	0.00001	531.052		"GT=790/809, CT=0/0, TT=116/99, TA=0/0"	"1,1,1"	
chr1:162724579	G/A	G	SNV		DDR2	exonic	1								10.52	p.Met117Ile		1407	"G=0.8948, A=0.1052"		+	5	NM_006182.2	c.351G>A	missense	2.67	0.12	10	0.325	"F5/8 type C domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,cell adhesion,chondrocyte proliferation,collagen binding,integral to plasma membrane,nucleotide binding,ossification,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of cell cycle arrest,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,protein autophosphorylation,receptor activity,regulation of bone mineralization,regulation of extracellular matrix disassembly,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"G=1259, A=148"	0.00001	208.992		"G=560/699, A=70/78"	1	
chr2:29416357	G/A	G	SNV		ALK	exonic	1								9.76	p.(=)		1998	"G=0.9024, A=0.0976"		-	29	NM_004304.4	c.4596C>T	synonymous	0.17				"MAM domain,Protein kinase domain,Protein tyrosine kinase"	rs1881422		0.023 (ref)	3.00E-04	0.0572	0.0196	YES	"ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"G=1803, A=195"	0.00001	232.267		"G=820/983, A=87/108"	2	
chr2:29416366	G/C	G	SNV		ALK	exonic	1								32.43	p.Asp1529Glu		1998	"G=0.6757, C=0.3243"		-	29	NM_004304.4	c.4587C>G	missense	-1.46	1	45	0	"MAM domain,Protein kinase domain,Protein tyrosine kinase"	rs1881421		0.435 (ref)	0.3438	0.3915	0.4335	YES	"ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"G=1350, C=648"	0.00001	3574.28		"G=611/739, C=296/352"	1	
chr2:29416572	C/C	T	SNV		ALK	exonic	1								100	p.Ile1461Val		1997	"T=0.0, C=1.0"		-	29	NM_004304.4	c.4381A>G	missense	-0.25	1	29	0	"MAM domain,Protein kinase domain,Protein tyrosine kinase"	rs1670283		0.007 (ref)	3.00E-04	0.0279	0.0097		"ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"T=0, C=1997"	0.00001	26916.2		"T=0/0, C=979/1018"	1	
chr2:29416615	G/A	G	SNV		ALK	exonic	1								33.1	p.(=)		2000	"G=0.669, A=0.331"		-	29	NM_004304.4	c.4338C>T	synonymous	-0.03				"MAM domain,Protein kinase domain,Protein tyrosine kinase"	rs56132472		0.074 (ref)	0.1126	0.0851	0.1033	YES	"ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"G=1338, A=662"	0.00001	3706.65		"G=639/699, A=341/321"	2	
chr2:29445458	G/T	G	SNV		ALK	exonic	1								11.8	p.(=)		1551	"G=0.882, T=0.118"		-	21	NM_004304.4	c.3375C>A	synonymous	-1.83				"MAM domain,Protein kinase domain,Protein tyrosine kinase"	rs3795850		0.395 (ref)	0.2058	0.2519	0.2214	YES	"ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"			"G=1368, T=183"	0.00001	315.169		"G=739/629, T=92/91"	1	
chr2:209113192	G/A	G	SNV		IDH1	exonic	1								8.3	p.(=)		2000	"G=0.917, A=0.083"		-	4	NM_005896.3	c.315C>T	synonymous	1.35				Isocitrate/isopropylmalate dehydrogenase	rs11554137		0.049 (ref)	0.0531	0.106	0.071	YES	"2-oxoglutarate metabolic process,NAD binding,NADPH regeneration,carbohydrate metabolic process,cellular lipid metabolic process,cytoplasm,cytosol,glutathione metabolic process,glyoxylate cycle,isocitrate dehydrogenase (NADP+) activity,isocitrate metabolic process,magnesium ion binding,mitochondrion,oxidoreductase activity,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,peroxisomal matrix,peroxisome,protein homodimerization activity,response to oxidative stress,tricarboxylic acid cycle"	"2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitric Acid"		"G=1834, A=166"	0.00001	135.513		"G=993/841, A=101/65"	1	
chr3:12632388	T/G	T	SNV		RAF1	exonic	1								5	p.Ser427Arg		1999	"T=0.95, G=0.05"		-	12	NM_002880.3	c.1279A>C	missense	2.12	0	110	1	"Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain"								"ATP binding,MAP kinase kinase kinase activity,MAPKKK cascade,Ras GTPase binding,Ras protein signal transduction,activation of MAPKK activity,apoptotic process,axon guidance,blood coagulation,cell proliferation,cytoplasm,cytoskeleton organization,cytosol,epidermal growth factor receptor signaling pathway,heart development,insoluble fraction,insulin receptor signaling pathway,metal ion binding,mitochondrial outer membrane,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of cell proliferation,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of protein complex assembly,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,regulation of Rho protein signal transduction,regulation of apoptotic process,regulation of cell differentiation,regulation of cell motility,response to hypoxia,signal transduction,small GTPase mediated signal transduction,synaptic transmission,wound healing"	Sorafenib		"T=1899, G=100"	0.11132	9.53412		"T=874/1025, G=53/47"	1	
chr3:41266101	C/A	C	SNV		CTNNB1	exonic	1	Hotspot	Gain-of-function			HS	COSM5673;COSM5677;COSM5669		"A=30.26, G=0.00, T=0.00"	p.Ser33Tyr		1411	"C=0.6974, A=0.3026, G=0.0, T=0.0"		+	3	NM_001904.3	c.98C>A	missense	2.73	0	144	1	Armadillo/beta-catenin-like repeat	rs121913400							"APC-Axin-1-beta-catenin complex,Axin-APC-beta-catenin-GSK3B complex,DNA binding,I-SMAD binding,R-SMAD binding,RPTP-like protein binding,SMAD binding,Schwann cell proliferation,Scrib-APC-beta-catenin complex,T cell differentiation in thymus,Wnt receptor signaling pathway,Z disc,adherens junction,adherens junction assembly,alpha-catenin binding,androgen receptor binding,androgen receptor signaling pathway,anterior/posterior axis specification,apical part of cell,apoptotic process,basolateral plasma membrane,beta-catenin-TCF7L2 complex,bone resorption,branching involved in ureteric bud morphogenesis,cadherin binding,canonical Wnt receptor signaling pathway,canonical Wnt receptor signaling pathway involved in negative regulation of apoptosis,canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition,catenin complex,cell adhesion,cell cortex,cell fate specification,cell junction,cell maturation,cell periphery,cell-cell adherens junction,cell-cell adhesion,cell-cell junction,cell-matrix adhesion,cell-substrate adherens junction,cellular component disassembly involved in apoptosis,cellular response to growth factor stimulus,cellular response to indole-3-methanol,cellular response to organic cyclic compound,central nervous system vasculogenesis,centrosome,chromatin binding,cytoplasm,cytoskeletal anchoring at plasma membrane,cytoskeleton,cytosol,dendritic shaft,desmosome,determination of dorsal/ventral asymmetry,dorsal/ventral axis specification,double-stranded DNA binding,ectoderm development,embryonic arm morphogenesis,embryonic axis specification,embryonic digit morphogenesis,embryonic foregut morphogenesis,embryonic heart tube development,embryonic hindlimb morphogenesis,embryonic limb morphogenesis,embryonic skeletal limb joint morphogenesis,endoderm formation,endodermal cell fate commitment,endothelial tube morphogenesis,enzyme binding,epithelial cell differentiation involved in prostate gland development,epithelial to mesenchymal transition,estrogen receptor binding,fascia adherens,forebrain development,fungiform papilla formation,gastrulation with mouth forming second,genitalia morphogenesis,glial cell fate determination,hair cell differentiation,hair follicle morphogenesis,hair follicle placode formation,hemopoiesis,hindbrain development,in utero embryonic development,internal side of plasma membrane,ion channel binding,ionotropic glutamate receptor binding,kinase binding,lamellipodium,lateral plasma membrane,lens morphogenesis in camera-type eye,limb development,liver development,lung cell differentiation,lung induction,lung-associated mesenchyme development,male genitalia development,membrane,membrane fraction,mesenchymal cell proliferation involved in lung development,mesenchymal to epithelial transition involved in metanephros morphogenesis,metanephros morphogenesis,microvillus membrane,midgut development,morphogenesis of embryonic epithelium,muscle cell differentiation,myoblast differentiation,negative regulation of cell proliferation,negative regulation of chondrocyte differentiation,negative regulation of heart induction by canonical Wnt receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of osteoclast differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,nephron tubule formation,neuron projection,nuclear hormone receptor binding,nucleus,odontogenesis of dentin-containing tooth,oocyte development,oviduct development,pancreas development,patterning of blood vessels,perinuclear region of cytoplasm,plasma membrane,positive regulation of I-kappaB kinase/NF-kappaB cascade,positive regulation of MAPKKK cascade,positive regulation of anti-apoptosis,positive regulation of apoptotic process,positive regulation of branching involved in lung morphogenesis,positive regulation of determination of dorsal identity,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation involved in prostate gland development,positive regulation of fibroblast growth factor receptor signaling pathway,positive regulation of heparan sulfate proteoglycan biosynthetic process,positive regulation of mesenchymal cell proliferation,positive regulation of muscle cell differentiation,positive regulation of osteoblast differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein C-terminus binding,protein binding,protein kinase binding,protein localization at cell surface,protein phosphatase binding,protein-DNA complex,proximal/distal pattern formation,regulation of T cell proliferation,regulation of angiogenesis,regulation of calcium ion import,regulation of centriole-centriole cohesion,regulation of centromeric sister chromatid cohesion,regulation of fibroblast proliferation,regulation of myelination,regulation of nephron tubule epithelial cell differentiation,regulation of protein localization at cell surface,regulation of smooth muscle cell proliferation,renal inner medulla development,renal outer medulla development,renal vesicle formation,repressing transcription factor binding,response to cadmium ion,response to cytokine stimulus,response to drug,response to estradiol stimulus,response to hormone stimulus,sequence-specific DNA binding transcription factor activity,signal transducer activity,skeletal system development,skin development,smooth muscle cell differentiation,spindle pole,structural molecule activity,synapse,synapse organization,synaptic vesicle transport,thymus development,tongue morphogenesis,trachea formation,transcription coactivator activity,transcription factor binding,transcription factor complex,transcription regulatory region DNA binding,zonula adherens"	Urea	other	"C=984, A=427, G=0, T=0"	0.00001	2633.69		"C=400/584, A=196/231, G=0/0, T=0/0"	"1,1,1"	
chr3:41266133	CCTT/C	CCTT	INDEL		CTNNB1	exonic	3	Hotspot	Gain-of-function			HS	COSM6128		7.03	p.Ser45del		1352	"CCTT=0.9297, C=0.0703"		+	3	NM_001904.3	c.133_135delTCT	nonframeshiftDeletion	"2.8,2.8,0.45,2.26"				Armadillo/beta-catenin-like repeat	rs121913407							"APC-Axin-1-beta-catenin complex,Axin-APC-beta-catenin-GSK3B complex,DNA binding,I-SMAD binding,R-SMAD binding,RPTP-like protein binding,SMAD binding,Schwann cell proliferation,Scrib-APC-beta-catenin complex,T cell differentiation in thymus,Wnt receptor signaling pathway,Z disc,adherens junction,adherens junction assembly,alpha-catenin binding,androgen receptor binding,androgen receptor signaling pathway,anterior/posterior axis specification,apical part of cell,apoptotic process,basolateral plasma membrane,beta-catenin-TCF7L2 complex,bone resorption,branching involved in ureteric bud morphogenesis,cadherin binding,canonical Wnt receptor signaling pathway,canonical Wnt receptor signaling pathway involved in negative regulation of apoptosis,canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition,catenin complex,cell adhesion,cell cortex,cell fate specification,cell junction,cell maturation,cell periphery,cell-cell adherens junction,cell-cell adhesion,cell-cell junction,cell-matrix adhesion,cell-substrate adherens junction,cellular component disassembly involved in apoptosis,cellular response to growth factor stimulus,cellular response to indole-3-methanol,cellular response to organic cyclic compound,central nervous system vasculogenesis,centrosome,chromatin binding,cytoplasm,cytoskeletal anchoring at plasma membrane,cytoskeleton,cytosol,dendritic shaft,desmosome,determination of dorsal/ventral asymmetry,dorsal/ventral axis specification,double-stranded DNA binding,ectoderm development,embryonic arm morphogenesis,embryonic axis specification,embryonic digit morphogenesis,embryonic foregut morphogenesis,embryonic heart tube development,embryonic hindlimb morphogenesis,embryonic limb morphogenesis,embryonic skeletal limb joint morphogenesis,endoderm formation,endodermal cell fate commitment,endothelial tube morphogenesis,enzyme binding,epithelial cell differentiation involved in prostate gland development,epithelial to mesenchymal transition,estrogen receptor binding,fascia adherens,forebrain development,fungiform papilla formation,gastrulation with mouth forming second,genitalia morphogenesis,glial cell fate determination,hair cell differentiation,hair follicle morphogenesis,hair follicle placode formation,hemopoiesis,hindbrain development,in utero embryonic development,internal side of plasma membrane,ion channel binding,ionotropic glutamate receptor binding,kinase binding,lamellipodium,lateral plasma membrane,lens morphogenesis in camera-type eye,limb development,liver development,lung cell differentiation,lung induction,lung-associated mesenchyme development,male genitalia development,membrane,membrane fraction,mesenchymal cell proliferation involved in lung development,mesenchymal to epithelial transition involved in metanephros morphogenesis,metanephros morphogenesis,microvillus membrane,midgut development,morphogenesis of embryonic epithelium,muscle cell differentiation,myoblast differentiation,negative regulation of cell proliferation,negative regulation of chondrocyte differentiation,negative regulation of heart induction by canonical Wnt receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of osteoclast differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,nephron tubule formation,neuron projection,nuclear hormone receptor binding,nucleus,odontogenesis of dentin-containing tooth,oocyte development,oviduct development,pancreas development,patterning of blood vessels,perinuclear region of cytoplasm,plasma membrane,positive regulation of I-kappaB kinase/NF-kappaB cascade,positive regulation of MAPKKK cascade,positive regulation of anti-apoptosis,positive regulation of apoptotic process,positive regulation of branching involved in lung morphogenesis,positive regulation of determination of dorsal identity,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation involved in prostate gland development,positive regulation of fibroblast growth factor receptor signaling pathway,positive regulation of heparan sulfate proteoglycan biosynthetic process,positive regulation of mesenchymal cell proliferation,positive regulation of muscle cell differentiation,positive regulation of osteoblast differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein C-terminus binding,protein binding,protein kinase binding,protein localization at cell surface,protein phosphatase binding,protein-DNA complex,proximal/distal pattern formation,regulation of T cell proliferation,regulation of angiogenesis,regulation of calcium ion import,regulation of centriole-centriole cohesion,regulation of centromeric sister chromatid cohesion,regulation of fibroblast proliferation,regulation of myelination,regulation of nephron tubule epithelial cell differentiation,regulation of protein localization at cell surface,regulation of smooth muscle cell proliferation,renal inner medulla development,renal outer medulla development,renal vesicle formation,repressing transcription factor binding,response to cadmium ion,response to cytokine stimulus,response to drug,response to estradiol stimulus,response to hormone stimulus,sequence-specific DNA binding transcription factor activity,signal transducer activity,skeletal system development,skin development,smooth muscle cell differentiation,spindle pole,structural molecule activity,synapse,synapse organization,synaptic vesicle transport,thymus development,tongue morphogenesis,trachea formation,transcription coactivator activity,transcription factor binding,transcription factor complex,transcription regulatory region DNA binding,zonula adherens"	Urea		"CCTT=1257, C=95"	0.00001	99.9471		"CCTT=533/724, C=11/84"	2	
chr3:178936091	G/A	G	SNV		PIK3CA	exonic	1	Hotspot	Gain-of-function			HS	COSM763;COSM27133		"A=7.72, C=0.00"	p.Glu545Lys		1451	"G=0.9228, A=0.0772, C=0.0"		+	10	NM_006218.2	c.1633G>A	missense	2.72	0	56	0.991	"PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family"	rs104886003							"1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction"	"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE"	"other,pathogenic"	"G=1339, A=112, C=0"	0.00001	141.739		"G=660/679, A=48/64, C=0/0"	"1,1"	
chr3:178947865	G/A	G	SNV		PIK3CA	exonic	1								32.72	p.Gly914Arg		1895	"G=0.6728, A=0.3272"		+	19	NM_006218.2	c.2740G>A	missense	2.65	0	125	0.966	"PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family"								"1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction"	"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE"		"G=1275, A=620"	0.00001	3442.47		"G=579/696, A=271/349"	2	
chr3:178952085	A/G	A	SNV		PIK3CA	exonic	1	Hotspot	Gain-of-function			HS	COSM249874;COSM775;COSM776		"C=0.00, G=18.37, T=0.00"	p.His1047Arg		860	"A=0.8163, C=0.0, G=0.1837, T=0.0"		+	21	NM_006218.2	c.3140A>G	missense	2.33	0.01	29	0.639	"PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family"	rs121913279							"1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction"	"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE"	other	"A=702, C=0, G=158, T=0"	0.00001	647.875		"A=348/354, C=0/0, G=78/80, T=0/0"	"1,1,1"	
chr4:1801137	T/TGG	TGGG	INDEL		FGFR3	"exonic, exonic"	3								"T=35.13, TGG=33.08"	"p.Gly90del, p.Gln92fs"		1953	"TGGG=0.318, T=0.3513, TGG=0.3308"		+	3	"NM_000142.4, NM_000142.4"	"c.268_270delGGG, c.270delG"	"nonframeshiftDeletion, frameshiftDeletion"	"0.52,1.91,1.91,1.91"				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development"	"Palifermin,Pazopanib"		"TGGG=621, T=686, TGG=646"	0.00001	8742.19		"TGGG=609/12, T=0/686, TGG=284/362"	"4,4"	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100	p.(=)		1423	"G=0.0, A=1.0"		+	14	NM_000142.4	c.1953G>A	synonymous	0.05				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs7688609		0.042 (ref)	8.00E-04	0.131	0.0449	YES	"ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development"	"Palifermin,Pazopanib"		"G=0, A=1423"	0.00001	19192.2		"G=0/0, A=753/670"	1	
chr4:55133726	T/G	T	SNV		PDGFRA	exonic	1								7.36	p.(=)		1509	"T=0.9264, G=0.0736"		+	7	NM_006206.4	c.939T>G	synonymous	-1.94				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs4358459		0.199 (ref)	0.12	0.2476	0.1632	YES	"ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing"	"Becaplermin,Imatinib,Pazopanib,Sunitinib"		"T=1398, G=111"	0.00001	66.864		"T=783/615, G=64/47"	3	
chr4:55141055	G/G	A	SNV		PDGFRA	exonic	1								100	p.(=)		1302	"A=0.0, G=1.0"		+	12	NM_006206.4	c.1701A>G	synonymous	-5.31				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	"rs121913270,rs121913271,rs1873778"		0.037 (ref)	0.0015	0.1185	0.0411	YES	"ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing"	"Becaplermin,Imatinib,Pazopanib,Sunitinib"		"A=0, G=1302"	0.00001	17499.3		"A=0/0, G=714/588"	1	
chr4:55152040	C/T	C	SNV		PDGFRA	exonic	1								16.95	p.(=)		2000	"C=0.8305, T=0.1695"		+	18	NM_006206.4	c.2472C>T	synonymous	0.47				"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs2228230		0.208 (ref)	0.1393	0.3134	0.1983	YES	"ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing"	"Becaplermin,Imatinib,Pazopanib,Sunitinib"		"C=1661, T=339"	0.00001	974.453		"C=826/835, T=164/175"	2	
chr4:55599321	A/T	A	SNV		KIT	exonic	1	Hotspot	Gain-of-function			HS	COSM24675;COSM12711;COSM1314		"C=0.00, G=0.00, T=11.44"	p.Asp816Val		1233	"A=0.8856, C=0.0, G=0.0, T=0.1144"		+	17	NM_000222.2	c.2447A>T	missense	2.15	0	152	0.991	"Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs121913507							"ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway"	"Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib"	pathogenic	"A=1092, C=0, G=0, T=141"	0.00001	338.232		"A=544/548, C=0/0, G=0/0, T=80/61"	"1,1,1"	
chr5:176517797	C/T	C	SNV		FGFR4	exonic	1								82.05	p.Pro136Leu		2000	"C=0.1795, T=0.8205"		+	4	NM_213647.1	c.407C>T	missense	1.12	0.3	98	0	"Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"	rs376618		0.185 (ref)	0.248	0.3393	0.2789	YES	"ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process"	Palifermin		"C=359, T=1641"	0.00001	18169		"C=201/158, T=974/667"	4	
chr5:176517985	A/G	A	SNV		FGFR4	exonic	1								36.6	p.(=)		817	"A=0.634, G=0.366"		+	5	NM_213647.1	c.483A>G	synonymous	-3.74				"Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process"	Palifermin		"A=518, G=299"	0.00001	1826.26		"A=267/251, G=276/23"	1	
chr7:55241707	G/A	G	SNV		EGFR	exonic	1	Hotspot	Gain-of-function			HS	COSM6252;COSM6253		"A=25.90, T=0.00"	p.Gly719Ser		2000	"G=0.741, A=0.259, T=0.0"		+	18	NM_005228.3	c.2155G>A	missense	2.75	0	56	1	"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs28929495							"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"	other	"G=1482, A=518, T=0"	0.00001	2841.11		"G=726/756, A=266/252, T=0/0"	"3,3"	
chr7:55249063	G/A	G	SNV		"EGFR,EGFR-AS1"	"exonic, exonic_nc"	1								14.3	p.(=)		2000	"G=0.857, A=0.143"		"+, -"	20	"NM_005228.3, NR_047551.1"	c.2361G>A	synonymous	2.8				"Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain"	rs1050171		0.418 (ref)	0.3962	0.4226	0.4576	YES	"AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity"	"Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474"		"G=1714, A=286"	0.00001	656.675		"G=870/844, A=154/132"	1	
chr7:128846374	G/A	G	SNV		SMO	exonic	1								8.05	p.Val404Met		2000	"G=0.9195, A=0.0805"		+	6	NM_005631.4	c.1210G>A	missense	2.49	0	21	0.999	"Frizzled/Smoothened family membrane region,Fz domain"								"G-protein coupled receptor activity,Golgi apparatus,PDZ domain binding,Wnt-activated receptor activity,Wnt-protein binding,adenohypophysis development,axon extension involved in axon guidance,canonical Wnt receptor signaling pathway,cardioblast differentiation,caveola,cell development,cell fate specification,cellular response to cholesterol,central nervous system neuron differentiation,cerebellar cortex morphogenesis,ciliary receptor clustering involved in smoothened signaling pathway,cilium,cytoplasm,detection of cell density by contact stimulus involved in contact inhibition,determination of left/right asymmetry in lateral mesoderm,determination of left/right symmetry,developmental growth,dorsal/ventral neural tube patterning,drug binding,embryonic camera-type eye development,embryonic digestive tract morphogenesis,embryonic neurocranium morphogenesis,embryonic viscerocranium morphogenesis,epithelial-mesenchymal cell signaling,exocrine pancreas development,facial nerve development,floor plate formation,forebrain morphogenesis,gonad development,heart looping,heart morphogenesis,in utero embryonic development,integral to membrane,intracellular membrane-bounded organelle,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,midgut development,multicellular organism growth,muscle cell fate commitment,negative regulation of DNA binding,negative regulation of apoptotic process,negative regulation of gene expression,negative regulation of transcription from RNA polymerase II promoter,neural crest cell migration,neuron fate commitment,neuron projection regeneration,neuronal cell body,odontogenesis of dentin-containing tooth,osteoblast differentiation,osteoblast proliferation,otolith morphogenesis,patched binding,pattern specification process,plasma membrane,positive regulation of branching involved in ureteric bud morphogenesis,positive regulation of epithelial cell proliferation,positive regulation of gene expression,positive regulation of hh target transcription factor activity,positive regulation of mesenchymal cell proliferation,positive regulation of neuroblast proliferation,positive regulation of smoothened signaling pathway,positive regulation of transcription from RNA polymerase II promoter,primary cilium,protein binding,protein localization to nucleus,protein stabilization,receptor activity,regulation of heart morphogenesis,renal system development,response to organic substance,response to wounding,semicircular canal morphogenesis,signal transducer activity,smoothened signaling pathway,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,smoothened signaling pathway involved in ventral spinal cord patterning,somite development,spermatogenesis,vasculogenesis,ventral midline determination"	Fluocinonide		"G=1839, A=161"	0.00001	121.119		"G=873/966, A=63/98"	1	
chr7:140453136	ACTG/TCTG	ACTG	SNV		BRAF	exonic	1	Hotspot	Gain-of-function			HS	COSM26504;COSM6137;COSM18443;COSM476;COSM1583011;COSM474;COSM249889;COSM473;COSM1127;COSM1735763		"ACTGTAGCTAGACCAAAATCTG=0.00, CCTG=0.09, GCTG=0.00, TCTG=10.72, CGTG=0.00, CTTG=0.00, TGTG=0.00, TTTG=0.00, CTCG=0.00, TTTA=0.00"	p.Val600Glu		1166	"ACTG=0.8919, ACTGTAGCTAGACCAAAATCTG=0.0, CCTG=9.0E-4, GCTG=0.0, TCTG=0.1072, CGTG=0.0, CTTG=0.0, TGTG=0.0, TTTG=0.0, CTCG=0.0, TTTA=0.0"		-	15	NM_004333.4	c.1799T>A	missense	"2.17,2.69,2.17,2.69"	0	121	0.971	"C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain"	"rs113488022,rs121913227,rs121913374,rs121913375,rs121913377,rs121913378"							"ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome"	"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib"	"other,pathogenic"	"ACTG=1040, ACTGTAGCTAGACCAAAATCTG=0, CCTG=1, GCTG=0, TCTG=125, CGTG=0, CTTG=0, TGTG=0, TTTG=0, CTCG=0, TTTA=0"	0.00001	277.1		"ACTG=507/533, ACTGTAGCTAGACCAAAATCTG=0/0, CCTG=0/1, GCTG=0/0, TCTG=65/60, CGTG=0/0, CTTG=0/0, TGTG=0/0, TTTG=0/0, CTCG=0/0, TTTA=0/0"	"1,1,1,1,1,1,1,1,1,1"	
chr7:140494209	G/A	G	SNV		BRAF	exonic	1								20.36	p.Arg347Ter		1213	"G=0.7964, A=0.2036"		-	8	NM_004333.4	c.1039C>T	nonsense	2.75				"C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain"								"ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome"	"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib"		"G=966, A=247"	0.00001	881.467		"G=444/522, A=114/133"	2	
chr8:38271765	G/A	G	SNV		FGFR1	exonic	1								9.57	p.(=)		1766	"G=0.9043, A=0.0957"		-	17	NM_001174067.1	c.2184C>T	synonymous	-2.88				"Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase"								"ATP binding,MAPKKK cascade,axon guidance,cell migration,chordate embryonic development,cytoplasm,cytoplasmic membrane-bounded vesicle,cytosol,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,heparin binding,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,neuron migration,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of neuron differentiation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of phospholipase activity,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell differentiation,regulation of transcription, DNA-dependent,skeletal system development,skeletal system morphogenesis"	"(E)-4-(3,5-difluorophenyl)-3H-pyrrolo2,3-bpyridin-3-ylidene(3-methoxyphenyl)methanol,3-(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE-2-INDOLINONE,3-(3-methoxybenzyl)-1H-pyrrolo2,3-bpyridine,Palifermin,SU4984"		"G=1597, A=169"	0.00001	194.559		"G=1091/506, A=114/55"	1	
chr8:128750540	A/G	A	SNV		MYC	exonic	1								24.7	p.Asn26Ser		2000	"A=0.753, G=0.247"		+	2	NM_002467.4	c.77A>G	missense	2.14	0.01	46	0.885	"Helix-loop-helix DNA-binding domain,Myc amino-terminal region,Myc leucine zipper domain"	rs4645959		0.019 (ref)	0.0397	0.0079	0.0289	YES	"DNA binding,E-box binding,MAPKKK cascade,branching involved in ureteric bud morphogenesis,canonical Wnt receptor signaling pathway,cell cycle arrest,cellular iron ion homeostasis,cellular response to UV,cellular response to drug,chromatin remodeling,chromosome organization,energy reserve metabolic process,fibroblast apoptosis,negative regulation of apoptotic process,negative regulation of cell division,negative regulation of fibroblast proliferation,negative regulation of monocyte differentiation,negative regulation of stress-activated MAPK cascade,negative regulation of transcription from RNA polymerase II promoter,nucleolus,nucleoplasm,nucleus,oxygen transport,positive regulation of DNA biosynthetic process,positive regulation of cell proliferation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of mesenchymal cell proliferation,positive regulation of metanephric cap mesenchymal cell proliferation,positive regulation of response to DNA damage stimulus,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein binding,protein complex,protein complex binding,regulation of telomere maintenance,repressing transcription factor binding,response to DNA damage stimulus,response to drug,response to gamma radiation,response to growth factor stimulus,sequence-specific DNA binding transcription factor activity,spindle,transcription factor binding"			"A=1506, G=494"	0.00001	2135.88		"A=817/689, G=274/220"	2	
chr10:43613843	G/T	G	SNV		RET	exonic	1								61.39	p.(=)		1997	"G=0.3861, T=0.6139"		+	13	NM_020975.4	c.2307G>T	synonymous	1.34				"Cadherin domain,Protein kinase domain,Protein tyrosine kinase"	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	"ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development"	"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib"	untested	"G=771, T=1226"	0.00001	10951.8		"G=412/359, T=633/593"	1	
chr12:25398281	CC/TC	CC	SNV		KRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM534;COSM533;COSM532;COSM525;COSM53283		"AC=0.00, GC=0.00, TC=16.38, AT=0.00, TT=0.00"	p.Gly13Asp		1325	"CC=0.8362, AC=0.0, GC=0.0, TC=0.1638, AT=0.0, TT=0.0"		-	2	NM_033360.3	c.38G>A	missense	"2.67,2.67"	0	94	0.803	"Miro-like protein,Ras family"	"rs112445441,rs121913535"							"GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior"	"(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE"	"other,pathogenic"	"CC=1108, AC=0, GC=0, TC=217, AT=0, TT=0"	0.00001	787.549		"CC=582/526, AC=0/0, GC=0/0, TC=95/122, AT=0/0, TT=0/0"	"2,2,2,2,2"	
chr12:25398284	CC/TC	CC	SNV		KRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM520;COSM522;COSM521;COSM512;COSM514;COSM34144;COSM25081;COSM13643		"AA=0.00, AC=0.00, AG=0.00, AT=0.00, GC=0.00, TA=0.00, TC=7.11, TT=0.00"	p.Gly12Asp		1322	"CC=0.9289, AA=0.0, AC=0.0, AG=0.0, AT=0.0, GC=0.0, TA=0.0, TC=0.0711, TT=0.0"		-	2	NM_033360.3	c.35G>A	missense	"2.67,2.67"	0	94	0.517	"Miro-like protein,Ras family"	"rs121913529,rs121913530"							"GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior"	"(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE"	other	"CC=1228, AA=0, AC=0, AG=0, AT=0, GC=0, TA=0, TC=94, TT=0"	0.00001	100.524		"CC=627/601, AA=0/0, AC=0/0, AG=0/0, AT=0/0, GC=0/0, TA=0/0, TC=48/46, TT=0/0"	"2,2,2,2,2,2,2,2"	
chr12:58143289	T/C	T	SNV		"CDK4,MIR6759"	"splicesite_5, upstream"	1								10.58			1134	"T=0.8942, C=0.1058"		-	6	"NM_000075.3, NR_106817.1"			2.23				"Protein kinase domain,Protein tyrosine kinase"								"ATP binding,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,S phase of mitotic cell cycle,cell cycle,cell division,chromatin,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytosol,membrane,mitotic cell cycle,nuclear membrane,nucleolus,nucleoplasm,nucleotide binding,nucleus,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,protein binding,protein phosphorylation,regulation of cell cycle,regulation of gene expression,response to drug,signal transduction,transcription factor complex"	"Flavopiridol,Purvalanol"		"T=1014, C=120"	0.00001	174.146		"T=483/531, C=59/61"	1	
chr15:66727451	A/C	A	SNV		MAP2K1	exonic	1								32.42	p.Gln56Pro		1974	"A=0.6758, C=0.3242"		+	2	NM_002755.3	c.167A>C	missense	1.91	0.02	76	0.702	"Protein kinase domain,Protein tyrosine kinase"								"ATP binding,Golgi apparatus,Golgi inheritance,MAP kinase kinase activity,MAPKKK cascade,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,Ras GTPase binding,Ras protein signal transduction,Toll signaling pathway,activation of MAPK activity,activation of MAPKK activity,axon guidance,axon part,cell cortex,cell cycle arrest,cell motility,cellular component movement,cellular senescence,chemotaxis,cytoplasm,cytoskeleton,cytosol,dendrite cytoplasm,epidermal growth factor receptor signaling pathway,innate immune response,insulin receptor signaling pathway,keratinocyte differentiation,labyrinthine layer development,melanosome transport,microtubule,mitogen-activated protein kinase kinase kinase binding,mitosis,negative regulation of cell proliferation,negative regulation of homotypic cell-cell adhesion,nerve growth factor receptor signaling pathway,neuron differentiation,neuron projection morphogenesis,nucleotide binding,nucleus,perikaryon,perinuclear region of cytoplasm,placenta blood vessel development,plasma membrane,positive regulation of Ras GTPase activity,positive regulation of Ras protein signal transduction,positive regulation of cell differentiation,positive regulation of cell migration,positive regulation of transcription elongation from RNA polymerase II promoter,protein binding,protein kinase activity,protein serine/threonine kinase activity,protein tyrosine kinase activity,receptor signaling protein tyrosine phosphatase activity,regulation of vascular smooth muscle contraction,response to axon injury,response to glucocorticoid stimulus,response to oxidative stress,signal transduction,small GTPase mediated signal transduction,soluble fraction,spindle pole body,stress-activated MAPK cascade,toll-like receptor 1 signaling pathway,toll-like receptor 2 signaling pathway,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,toll-like receptor signaling pathway,vesicle transport along microtubule"	"(5S)-4,5-difluoro-6-(2-fluoro-4-iodophenyl)imino-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide,2-(2-chloro-4-iodophenyl)amino-N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluorobenzamide,2-(4-ETHYNYL-2-FLUOROPHENYL)AMINO-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE,5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-(2-Fluoro-4-Iodophenyl)AminoBenzamide,K-252a,N-(5-{3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminophenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine,N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminobenzamide"		"A=1334, C=640"	0.00001	3516.71		"A=755/579, C=379/261"	1	
chr15:66729147	C/T	C	SNV		MAP2K1	exonic	1								31.25	p.His119Tyr		2000	"C=0.6875, T=0.3125"		+	3	NM_002755.3	c.355C>T	missense	2.38	0	83	0.999	"Protein kinase domain,Protein tyrosine kinase"								"ATP binding,Golgi apparatus,Golgi inheritance,MAP kinase kinase activity,MAPKKK cascade,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,Ras GTPase binding,Ras protein signal transduction,Toll signaling pathway,activation of MAPK activity,activation of MAPKK activity,axon guidance,axon part,cell cortex,cell cycle arrest,cell motility,cellular component movement,cellular senescence,chemotaxis,cytoplasm,cytoskeleton,cytosol,dendrite cytoplasm,epidermal growth factor receptor signaling pathway,innate immune response,insulin receptor signaling pathway,keratinocyte differentiation,labyrinthine layer development,melanosome transport,microtubule,mitogen-activated protein kinase kinase kinase binding,mitosis,negative regulation of cell proliferation,negative regulation of homotypic cell-cell adhesion,nerve growth factor receptor signaling pathway,neuron differentiation,neuron projection morphogenesis,nucleotide binding,nucleus,perikaryon,perinuclear region of cytoplasm,placenta blood vessel development,plasma membrane,positive regulation of Ras GTPase activity,positive regulation of Ras protein signal transduction,positive regulation of cell differentiation,positive regulation of cell migration,positive regulation of transcription elongation from RNA polymerase II promoter,protein binding,protein kinase activity,protein serine/threonine kinase activity,protein tyrosine kinase activity,receptor signaling protein tyrosine phosphatase activity,regulation of vascular smooth muscle contraction,response to axon injury,response to glucocorticoid stimulus,response to oxidative stress,signal transduction,small GTPase mediated signal transduction,soluble fraction,spindle pole body,stress-activated MAPK cascade,toll-like receptor 1 signaling pathway,toll-like receptor 2 signaling pathway,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,toll-like receptor signaling pathway,vesicle transport along microtubule"	"(5S)-4,5-difluoro-6-(2-fluoro-4-iodophenyl)imino-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide,2-(2-chloro-4-iodophenyl)amino-N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluorobenzamide,2-(4-ETHYNYL-2-FLUOROPHENYL)AMINO-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE,5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-(2-Fluoro-4-Iodophenyl)AminoBenzamide,K-252a,N-(5-{3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminophenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine,N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminobenzamide"		"C=1375, T=625"	0.00001	3340.87		"C=766/609, T=320/305"	1	
chr19:4117528	G/A	G	SNV		MAP2K2	exonic	1								17.2	p.(=)		2000	"G=0.828, A=0.172"		-	2	NM_030662.3	c.192C>T	synonymous	-0.47				"Protein kinase domain,Protein tyrosine kinase"	rs8157		0.049 (ref)	0.0599	0.0695	0.0631	YES	"ATP binding,ERK1 and ERK2 cascade,MAP kinase kinase activity,MAPKKK cascade,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,Ras protein signal transduction,Toll signaling pathway,activation of MAPK activity,activation of MAPKK activity,axon guidance,cell cortex,cytosol,epidermal growth factor receptor signaling pathway,extracellular region,innate immune response,insulin receptor signaling pathway,nerve growth factor receptor signaling pathway,nucleotide binding,positive regulation of cell motility,protein binding,protein complex scaffold,protein phosphorylation,protein serine/threonine kinase activity,protein tyrosine kinase activity,small GTPase mediated signal transduction,soluble fraction,stress-activated MAPK cascade,toll-like receptor 1 signaling pathway,toll-like receptor 2 signaling pathway,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,toll-like receptor signaling pathway"			"G=1656, A=344"	0.00001	1006.75		"G=716/940, A=163/181"	1	